| Bioactivity | Btk inhibitor 2 (BGB-3111 analog) is a Bruton's tyrosine kinase (BTK) inhibitor extracted from patent US 20170224688 A1. | ||||||||||||
| Target | BTK | ||||||||||||
| Name | Btk inhibitor 2 | ||||||||||||
| CAS | 1558036-85-3 | ||||||||||||
| Formula | C24H25N5O3 | ||||||||||||
| Molar Mass | 431.49 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Cecile M. Krejsa. Methods of Using BTK Inhibitors to Treat Dermatoses. US 20170224688 A1. |
Btk inhibitor 2
CAS: 1558036-85-3 F: C24H25N5O3 W: 431.49
Btk inhibitor 2 (BGB-3111 analog) is a Bruton's tyrosine kinase (BTK) inhibitor extracted from patent US 20170224688 A1.
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.